Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma ~93 mi. (Lages, Brazil, +118 more cities) Regeneron Research Site Skin Squamous Cell Carcinoma cemiplimab immunotherapy